Foghorn Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.21

+0.21 (+4.20%)

As of Mar 23, 3:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +456.4% upside

Low Target $18.54

Average Target $28.99

High Target $38.99

Current Price $5.21

Current
$5.21

Target
$28.99

$18.54 $28.99 avg $38.99

Scenario Analysis

Bear Case

$18.54

255.9%

Low target

Base Case

$28.99

+456.4%

Avg target

Bull Case

$38.99

+648.4%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$6.95

-25.0% from high

52-Week Low

$2.94

+76.9% from low

Target vs 52W High

$28.99

+317.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%